Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
Abstract: Iron-overload-associated cardiomyopathy has been one of the primary causes of mortality in thalassemia patients with iron burden. There is growing evidence citing the beneficial effects of ebselen as an antioxidant selectively blocking the divalent metal transporter 1 (DMT-1) to deter iron ingress into cardiomyocytes, raising internets in viewing this component in this population in order to treat and even prevent cardiomyopathy occurring from iron surplus. In this article, we reviewed the potential advantageous effects of ebselen in thalassemia patients who suffer from iron excess, susceptible to cardiomyopathy induced by iron overload. A systematic search in several databases, including PubMed, Scopus, and Web of Science, was conducted to explore the role of ebselen in controlling iron-overload-related cardiomyopathy in thalassemia patients by the keywords of Ebselen AND iron. The inclusion criteria were English-written preclinical and clinical studies investigating the efficacy and side effects of ebselen in an iron-overload context. After searching the databases, 44 articles were found. Next, of 19 published articles, 3 were included in this article. After reviewing the references of the included studies, no articles were added. In conclusion ebselen can be a promising adjuvant therapy in patients with thalassemia alongside the standard treatment with iron chelators, particularly in severe cases with cardiomyopathy, due to falling iron inflow by inhibiting DMT-1 and increasing ferroportin-1 expression and antioxidant properties. However, clinical studies need to be carried out to reach a definite conclusion.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients ; volume:18 ; number:1 ; year:2023 ; extent:8
Open medicine ; 18, Heft 1 (2023) (gesamt 8)
- Urheber
-
Ghazaiean, Mobin
Aliasgharian, Aily
Karami, Hossein
Darvishi-Khezri, Hadi
- DOI
-
10.1515/med-2023-0733
- URN
-
urn:nbn:de:101:1-2023071314052746590962
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghazaiean, Mobin
- Aliasgharian, Aily
- Karami, Hossein
- Darvishi-Khezri, Hadi
Ähnliche Objekte (12)
Iron-regulatory proteins secure iron availability in cardiomyocytes and prevent heart failure
Erythrocyte labile iron pool indicating concealed iron overload in non-transfusion-dependent β-thalassemia
Myocardial iron overload in sickle/thalassemia patients of Italian origin
Myocardial iron overload in thalassemia major. How early to check?
Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress
Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes
Nitriding of iron-based alloys : the role of excess nitrogen
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis
Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients
The J anus transcription factor H ap X controls fungal adaptation to both iron starvation and iron excess
Transcriptomic analysis of rice in response to iron deficiency and excess
Iron-regulatory proteins secure iron availability in cardiomyocytes and prevent heart failure
Erythrocyte labile iron pool indicating concealed iron overload in non-transfusion-dependent β-thalassemia
Myocardial iron overload in sickle/thalassemia patients of Italian origin
Myocardial iron overload in thalassemia major. How early to check?
Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress
Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes
Nitriding of iron-based alloys : the role of excess nitrogen
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis
Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients
The J anus transcription factor H ap X controls fungal adaptation to both iron starvation and iron excess
Transcriptomic analysis of rice in response to iron deficiency and excess
Iron-regulatory proteins secure iron availability in cardiomyocytes and prevent heart failure
Erythrocyte labile iron pool indicating concealed iron overload in non-transfusion-dependent β-thalassemia
Myocardial iron overload in sickle/thalassemia patients of Italian origin
Myocardial iron overload in thalassemia major. How early to check?
Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress
Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes
Nitriding of iron-based alloys : the role of excess nitrogen
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis
Global longitudinal strain as an Indicator of cardiac Iron overload in thalassemia patients
The J anus transcription factor H ap X controls fungal adaptation to both iron starvation and iron excess